Cargando…

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway

BACKGROUND: Although cisplatin is an effective chemotherapeutic drug that is commonly used for non-small-cell lung cancer (NSCLC) treatment, the drug resistance usually occurs during the long-term use of it. It is urgent to develop strategies to reduce the resistance of NSCLC cells to cisplatin. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhilai, Pan, Jianguang, Chen, Lei, Wang, Xinhang, Chen, Yuhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443038/ https://www.ncbi.nlm.nih.gov/pubmed/32884297 http://dx.doi.org/10.2147/OTT.S261799

Ejemplares similares

MiR-124 sensitizes cisplatin-induced cytotoxicity against CD133(+) hepatocellular carcinoma cells by targeting SIRT1/ROS/JNK pathway
por: Xu, Yunxiuxiu, et al.
Publicado: (2019)

Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
por: Chun, Jaemoo
Publicado: (2023)

Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
por: Ma, Yuzhu, et al.
Publicado: (2019)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun
por: Huang, Gang, et al.
Publicado: (2017)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2020)

Restoration of miR-26b expression partially reverses the cisplatin resistance of NSCLC by targeting tafazzin
por: Zang, Shuzhi, et al.
Publicado: (2019)

Cordycepin Resensitizes T24R2 Cisplatin-Resistant Human Bladder Cancer Cells to Cisplatin by Inactivating Ets-1 Dependent MDR1 Transcription
por: Oh, Sang-Seok, et al.
Publicado: (2020)

Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
por: Echevarría-Vargas, Ileabett M., et al.
Publicado: (2014)

Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2
por: Ke, Bin, et al.
Publicado: (2019)

Correction: Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
Publicado: (2014)

MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
por: Wang, Xiaoyuan, et al.
Publicado: (2015)

Osthole resensitizes CD133(+) hepatocellular carcinoma cells to cisplatin treatment via PTEN/AKT pathway
por: Ye, Junfeng, et al.
Publicado: (2020)

Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
por: Ye, Zhiqiang, et al.
Publicado: (2016)

Inhaled Cisplatin for NSCLC: Facts and Results
por: Kosmidis, Christoforos, et al.
Publicado: (2019)

miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
por: Lin, Chen, et al.
Publicado: (2018)

Piperlongumine increases the sensitivity of bladder cancer to cisplatin by mitochondrial ROS
por: Pan, Xiaobo, et al.
Publicado: (2022)

miRNA 17 Family Regulates Cisplatin-Resistant and Metastasis by Targeting TGFbetaR2 in NSCLC
por: Jiang, Zeyong, et al.
Publicado: (2014)

Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition
por: Wang, Qiong, et al.
Publicado: (2014)

Dysregulation of both miR-140-3p and miR-140-5p in synovial fluid correlate with osteoarthritis severity
por: Yin, C-M., et al.
Publicado: (2017)

Author Correction: MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC
por: Wang, Xiaoyuan, et al.
Publicado: (2022)

miR-140-3p enhances cisplatin sensitivity and attenuates stem cell-like properties through repressing Wnt/β-catenin signaling in lung adenocarcinoma cells
por: Wu, Shuoming, et al.
Publicado: (2020)

miR-140-5p and miR-140-3p: Key Actors in Aging-Related Diseases?
por: Toury, Léa, et al.
Publicado: (2022)

Midazolam increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via the miR-194-5p/HOOK3 axis
por: Sun, Tingting, et al.
Publicado: (2021)

Overexpression of miR-203 increases the sensitivity of NSCLC A549/H460 cell lines to cisplatin by targeting Dickkopf-1
por: Cheng, Ruirui, et al.
Publicado: (2022)

Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway
por: Chen, Baishen, et al.
Publicado: (2019)

Lidocaine represses proliferation and cisplatin resistance in cutaneous squamous cell carcinoma via miR-30c/SIRT1 regulation
por: Liu, Tao, et al.
Publicado: (2022)

MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer
por: Li, Maolan, et al.
Publicado: (2016)

Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022)

Upregulation of miR-146a increases cisplatin sensitivity of the non-small cell lung cancer A549 cell line by targeting JNK-2
por: Pang, Linrong, et al.
Publicado: (2017)

miR-1271 enhances the sensitivity of colorectal cancer cells to cisplatin
por: Yao, Huixiang, et al.
Publicado: (2019)

miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1
por: Song, Xiang, et al.
Publicado: (2019)

HOTTIP Enhances Gemcitabine and Cisplatin Resistance Through Sponging miR-637 in Cholangiocarcinoma
por: Gao, Kun, et al.
Publicado: (2021)

NLRX1 accelerates cisplatin-induced ototoxity in HEI-OC1 cells via promoting generation of ROS and activation of JNK signaling pathway
por: Yin, Haiyan, et al.
Publicado: (2017)

Hypoxia-induced PVT1 promotes lung cancer chemoresistance to cisplatin by autophagy via PVT1/miR-140-3p/ATG5 axis
por: Wang, Jiying, et al.
Publicado: (2022)

LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p
por: Wei, Lei, et al.
Publicado: (2019)

MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells
por: Li, Ningwei, et al.
Publicado: (2015)

MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1
por: Zhang, Yajie, et al.
Publicado: (2016)

Isodeoxyelephantopin Inactivates Thioredoxin Reductase 1 and Activates ROS-Mediated JNK Signaling Pathway to Exacerbate Cisplatin Effectiveness in Human Colon Cancer Cells
por: Hong, Lin, et al.
Publicado: (2020)

Daphnetin Attenuated Cisplatin-Induced Acute Nephrotoxicity With Enhancing Antitumor Activity of Cisplatin by Upregulating SIRT1/SIRT6-Nrf2 Pathway
por: Fan, Xiaoye, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g97729non41th9pe7jsq01gvmh